The company is rolling out a set of medical marijuana products in a market far overseas.
News & Analysis: HEXO Corp.
It's unlikely these pot stocks will be showing shareholders the green anytime soon.
An analyst is more bullish about the Canadian marijuana stock.
Here's why investors are excited about this troubled cannabis company that is making a comeback.
The company's coming off a third-quarter performance that wasn't all that impressive.
Goodwill isn't the only cause for concern on marijuana companies' balance sheets.
Pot stock valuations have plummeted, and these CEOs could pay the price for this underperformance.
This cannabis stock isn't worth the trouble, even with its shares trading for about $1 apiece.
A new class-action lawsuit is a buzz kill for the two Canadian peers.
After a string of bad news, HEXO’s third-quarter results came as a wee bit of a surprise.